Blog Detail
The Myelin Repair Foundation Blog
http://blog.myelinrepair.org
Unbounded by traditional medical research models, the Myelin Repair Foundation (MRF) established the potential of myelin repair as an alternative to current immunosuppressant therapies for multiple sclerosis. The MRF blog shares information about our approach, our findings and our best practices. Join the discussion and help break down the barriers that are slowing medical research for all diseases.
Recent Posts
-
39QHQ9E863W8 ...
Our Animal Models for Multiple Sclerosis Research
Recently, Dr. Zamboni invited scientists to create new animal models for MS research due to the limitations of the current EAE (experimental autoimmune encephalomyelitis) animal model in answering questions about the efficacy of CCSVI. In June, Rust...
Darla’s Message to MS: “To live with fear is a life half-lived”
I met Darla Bongiovanni in September when she was just starting her first year of classes at SUNY-Purchase in New York. Darla’s not just a undergrad student, she is also musician turned science major who was diagnosed with MS a few years ago....
Auction this Week: Get Moving and Bid on this Framed Photograph
We blogged back in September that Courtney Carver, a photographer and cyclist, who was Dx’ed with MS in July of 2006 launched The Ride Project to support the Myelin Repair Foundation. Courtney believes in our unique research model that is sole...
Thank you, Wheelchair Kamikaze
Thank you to Marc from The Wheelchair Kamikaze for taking the time to meet with Rusty Bromley while he was attending Partnering for Cures last week and for the covering our meeting with him on his blog: The Myelin Repair Foundation-The MRF, also foun...
The Myelin Repair Foundation’s Views on Chronic Cerebrospinal Venous Insufficiency (CCSVI) & Multiple Sclerosis
The Myelin Repair Foundation shares your optimism surrounding recent observations of malformations in cerebrospinal veins associated with blood flow defects in MS patients. Much of the research has been published by Dr. Paolo Zamboni and colleagues ...

